Opus Genetics IRD Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's stock issued during period, value, stock options exercised?
- Opus Genetics (IRD) reported stock issued during period, value, stock options exercised of $738K in Q1 2026.
- How has Opus Genetics's stock issued during period, value, stock options exercised changed year-over-year?
- Opus Genetics's stock issued during period, value, stock options exercised increased by 14660.0% year-over-year, from $5K to $738K.
- What does stock issued during period, value, stock options exercised mean?
- The total cash proceeds generated from the exercise of employee or director stock options. This metric indicates the extent to which equity-based compensation plans are being converted into actual share ownership by participants.